Latest News

WillScot Holdings (WSC) recently made its fencing and perimeter security offering available nationwide, giving the company another way to support construction, event, and high risk sites alongside its modular and storage solutions. See our latest analysis for WillScot Holdings. Despite the fencing rollout, recent trading has been weak, with a 7 day share price return of 10.87% and a 30 day share price return of 13.48%. This has fed into a 1 year total shareholder return decline of 30.54%,...

Napco Security Technologies recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, highlighting its electronic security solutions business and long-term roadmap. The company’s focus on high-margin recurring revenue and ongoing analyst interest in its operating performance has put its evolving business model under a brighter spotlight. Next, we’ll examine how this renewed analyst confidence around recurring revenue growth could influence Napco...

In early March 2026, Sumitomo Pharma secured conditional Japanese approval for AMCHePRY, the world’s first iPS cell-derived regenerative therapy for Parkinson’s disease patients whose symptoms are not adequately controlled by existing drugs, while also raising its full-year revenue and profit guidance, helped by stronger GEMTESA sales in North America and a weaker yen. The company’s decision on the same day to prepare a shelf registration for potential new share issuance, alongside its...

Capricorn Metals has reported past half-year results to 31 December 2025 showing revenue of A$327.48 million and net income of A$124.7 million, alongside guidance that it is on track for the upper end of its FY26 gold production range of 115,000–125,000 ounces at an AISC of A$1,530–A$1,630 per ounce. The company also declared its first fully franked ordinary dividend of A$0.05 per share for the half-year, signalling a shift toward direct cash returns to shareholders while continuing to use...

Positive Phase 3 data for PADCEV plus Keytruda in muscle invasive bladder cancer has put Astellas Pharma (TSE:4503) in focus, as investors weigh what the EV-304 results could mean for its oncology franchise. See our latest analysis for Astellas Pharma. The positive EV-304 update lands after a 19.78% 90 day share price return and a 12.86% year to date share price return, alongside a 73.33% 1 year total shareholder return that points to strong ongoing momentum. If this oncology news has you...

C3.ai (NYSE:AI) is under legal scrutiny after shareholders filed lawsuits alleging securities law violations and breaches of fiduciary duty. The actions follow disappointing financial results, a challenging CEO transition, and claims that material adverse information about sales and growth prospects was not properly disclosed. Regulatory and legal investigations are ongoing, raising questions about the company’s governance and leadership oversight. C3.ai, trading at $9.19, is in the...

AI restructure, e2open integration and earnings set the tone WiseTech Global (ASX:WTC) has been in focus after its half year 2026 results, an AI led restructure involving up to 2,000 job cuts, and earlier than planned cost synergies from the e2open acquisition. On the same day, the company also reported a fully franked interim dividend, reaffirmed its fiscal 2026 revenue guidance in the US$1.39b to US$1.44b range, and outlined how these moves fit into a broader shift toward an AI led...

Dynatrace executive Stephen McMahon recently purchased a significant amount of NYSE:DT stock, according to a regulatory filing. The purchase comes shortly after the company highlighted its focus on artificial intelligence at a major technology conference. The move is being watched by investors as a potential signal of internal confidence at a current share price of $39.28. For investors tracking NYSE:DT, this insider buying lands at a time when the stock has seen mixed recent performance...

Nutex Health (NUTX) is back in focus after reporting full year 2025 results and unveiling a fresh share repurchase program, pairing weaker Q4 numbers with a new commitment to buying back stock. See our latest analysis for Nutex Health. The Q4 earnings miss and new buyback plan landed against a sharp reset in sentiment. A 90 day share price return of 50.14% decline and year to date share price return of 39.08% decline contrast with a 1 year total shareholder return of 102.15%, suggesting...

If you are wondering whether Lithia Motors' current share price reflects its true worth, you are not alone. This article is designed to help you unpack that question clearly. The stock last closed at US$259.65, with recent returns of a 7.1% decline over 7 days, a 24.6% decline over 30 days, a 21.9% decline year to date, and a 14.2% decline over 1 year, while the 3 year return is 7.9% and the 5 year return is a 32.2% decline. Recent share price moves have put more attention on how the market...

Spin Master (TSX:TOY) has recorded major non cash impairment charges tied largely to its Melissa & Doug brand, contributing to a sizeable net loss. The company is contending with a weak U.S. toy market and tariffs, which have weighed on recent results. Management is putting more focus on digital games and new toy launches, including an expansion of its award winning Primal Hatch brand. Spin Master enters this period with its share price at CA$18.47 and a 1 year return of 29.1% decline,...

A Brazilian court halted Equinox Gold's transfer of mineral rights tied to a $1b sale of gold mines to China's CMOC Group. The decision follows a legal challenge from a state run firm that claims a contract breach in the transaction. The ruling directly affects a major asset sale and adds legal uncertainty around Equinox Gold's Brazilian operations. For you as an investor following TSX:EQX, this court action lands in the middle of the company's role as a mid tier gold producer with assets...

Nexi S.p.A. has announced an annual dividend of €0.3000 per share payable on May 20, 2026, following full-year 2025 results that showed sales of €6,273 million and a net loss of €3,377 million versus a net profit a year earlier. At the same time, Nexi is deepening its work with Google Cloud and open commerce standards to support AI-driven “agentic commerce,” aiming to pair advanced payments infrastructure with emerging shopping and fraud-detection technologies. We’ll now examine how Nexi’s...

Crocs, Inc. (NasdaqGS:CROX) is under pressure to address underwhelming growth and concerns over returns on capital. Management is also focused on lifting the company’s free cash flow margin, which is drawing attention to how that cash could be used. The combination of softer revenue trends, declining returns on capital and rising free cash flow is raising fresh questions about Crocs’ priorities. Crocs is best known for its foam clogs and casual footwear, a segment that has attracted intense...

FormFactor (NasdaqGS:FORM) has announced an upcoming Investor Day event. Executive leadership plans to outline the company’s priorities, long term growth opportunities, and operational initiatives. The event is intended to give investors and stakeholders direct access to the company’s senior team and its plans. FormFactor focuses on test and measurement solutions for the semiconductor industry, a part of the market that sits close to chip development and production. An Investor Day centered...

Intro Atos (ENXTPA:ATO) has just reported its FY 2025 results with first half revenue of €4.0b and a basic EPS loss of €37.36, alongside net income excluding extra items of a €696m loss. Over recent reporting periods the company has seen revenue move from €5.0b in the first half of 2024 to €4.6b in the second half of 2024 and €4.0b in the first half of 2025, while EPS has swung from a €174,754.66 loss in early 2024 to a €1,531.47 gain in late 2024 before landing at a €37.36 loss most...

Quanta Services (NYSE:PWR) has approved new annual and long term incentive plans for 2026. The plans apply to employees and senior leadership, with performance metrics tied to profitability, capital efficiency, safety, and shareholder value. The changes follow a period of strong quarterly results and recent acquisitions that support a positive growth outlook. Quanta Services, a contractor focused on infrastructure projects, is leaning into performance based pay at a time when investors are...

If you are wondering whether Kyocera's share price still reflects good value, this article walks through what the numbers actually say about the stock. Kyocera shares last closed at ¥2,641, with returns of 2.3% over 30 days, 18.4% year to date, 59.6% over 1 year, 66.6% over 3 years and 61.9% over 5 years, despite a 4.4% decline in the last 7 days. Recent coverage has focused on Kyocera's position in the broader tech sector and how investors are reassessing established manufacturers in light...

If you are wondering whether Gap's recent share price gives you value or just noise, this article will walk through what the numbers are actually saying about the stock. Gap finished the latest session at US$23.28, with a 17% decline over the past 7 days and 19.8% over the past 30 days, while still showing a 3.7% return over 1 year and a very large 3 year gain alongside an 8.4% decline over 5 years. Recent coverage around Gap has focused on how investors are reassessing traditional apparel...

Shurgard Self Storage (ENXTBR:SHUR) caught investor attention after releasing its 2025 results, reporting revenue of €450.85 million and net income of €597.76 million, along with fresh 2026 guidance for 6% to 8% all store revenue growth. See our latest analysis for Shurgard Self Storage. The latest guidance and 2025 results came after a weak patch for the shares, with a 30-day share price return showing a 10.62% decline and a 1-year total shareholder return showing a 9.73% decline. The recent...

Clear Secure has partnered with Mount Sinai Health System to roll out its CLEAR1 digital identity platform across one of New York City's largest health systems. The collaboration focuses on improving digital experiences for patients and staff while helping streamline day to day healthcare operations. The move reflects Clear Secure's push beyond travel use cases into healthcare, applying its identity technology in a large scale clinical setting. For investors watching Clear Secure...

Niagen Bioscience recently reported its strongest year to date, with 2025 net sales reaching US$129.4 million, net income of US$17.4 million, and management guiding for 2026 net sales to grow a further 10%–15% year-over-year excluding divested analytical reference standards and services revenue. Alongside this financial progress, the company deepened its intellectual property around nicotinamide riboside injectables and broadened into new categories such as at-home injection kits and...

Sopra Steria Group (ENXTPA:SOP) is back in focus after reporting 2025 earnings that combined lower sales with higher net income and earnings per share, along with a proposed dividend increase for shareholders. See our latest analysis for Sopra Steria Group. The share price reaction has been positive around these results, with a 1-day share price return of 3.86% and a 7-day share price return of 4.65% at €137.3. However, the year-to-date share price return of an 8.95% decline and the 1-year...

BioGaia (OM:BIOG B) shares are in focus after the company renewed and expanded its distribution agreement with Ewopharma. The agreement gives Ewopharma rights to distribute a broad probiotic portfolio across more than 15 European countries. See our latest analysis for BioGaia. At a share price of SEK110.3, BioGaia has seen modest short term weakness, with recent 1 day, 7 day and 30 day share price returns slightly negative. However, the 90 day share price return of 11.98% and multi year total...